title: Legionella pneumonia and serum procalcitonin.
abstract: Procalcitonin is a specific marker of severe bacterial infections with systemic inflammation. Quantitative evaluation of serum procalcitonin was performed in 140 patients with Legionella pneumonia. Positive values (>0.5 ng/mL) were found in 57.1% of the subjects. The positive sample rate was higher in early sera (73.9% in the first week) and decreased progressively. Mean values and the positive sample rate (69.8%) were higher in sera collected in the first 2 weeks of disease. Procalcitonin was positive in 86.7% of legionellosis cases confirmed by culture and mean positive values were significantly higher (P < 0.001) than those of culture-negative subjects. We conclude that procalcitonin can represent a useful prognostic marker for severe suspected Legionella pneumonia in the first 2 weeks of disease.
authors.affiliation: Infectious Diseases Unit, University of Turin, Corso Svizzera 164, Turin, 10149, Italy. franzin@asl3.to.it
authors.forename: Laura
authors.initials: L
authors.lastname: Franzin
authors.forename: Daniela
authors.initials: D
authors.lastname: Cabodi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007877:Legionnaires' Disease / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011498:Protein Precursors / Q000097:blood*
chemical_list: C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide
references.citation: MMWR Recomm Rep. 1997 Jan 3;46(RR-1):1-79
references.pmid: 9036304
references.citation: BMJ. 2002 Aug 17;325(7360):347-8
references.pmid: 12183289
references.citation: Clin Infect Dis. 2003 Jan 1;36(1):64-9
references.pmid: 12491204
references.citation: J Infect Dis. 2001 Apr 1;183(7):1161-4
references.pmid: 11237849
references.citation: Clin Microbiol Rev. 2002 Jul;15(3):506-26
references.pmid: 12097254
references.citation: Crit Care Med. 1999 Oct;27(10 ):2172-6
references.pmid: 10548201
references.citation: Intensive Care Med. 2000 Mar;26 Suppl 2:S187-92
references.pmid: 18470718
references.citation: Clin Infect Dis. 2002 Nov 1;35(9):1039-46
references.pmid: 12384836
references.citation: Pediatr Infect Dis J. 2000 Aug;19(8):679-87; quiz 688
references.pmid: 10959733
references.citation: Clin Infect Dis. 1993 Jun;16(6):741-7
references.pmid: 8329504
references.citation: Arch Dis Child. 2001 Apr;84(4):332-6
references.pmid: 11259234
references.citation: N Engl J Med. 1997 Sep 4;337(10):682-7
references.pmid: 9278466
references.citation: Anesthesiology. 2002 Jan;96(1):74-9
references.pmid: 11753005
references.citation: Clin Infect Dis. 2002 Apr 1;34(7):895-901
references.pmid: 11880953
references.citation: Lancet. 1993 Feb 27;341(8844):515-8
references.pmid: 8094770
references.citation: Clin Microbiol Infect. 2002 Feb;8(2):93-100
references.pmid: 11952722
references.citation: Am J Med Sci. 1996 Jul;312(1):12-8
references.pmid: 8686724